NASDAQ: ANIP
Ani Pharmaceuticals Inc Earnings Dates, Reports, Calls

Ani Pharmaceuticals earnings were $116.8M for the trailing 12 months ending Sep 30, 2026, with 202.9% growth year over year. The latest ANIP earnings report on Sep 30, 2026 announced Q3 2026 earnings of $35.1M, up 42.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ANIP reported annual earnings of $77.2M, with -483.1% growth.

ANIP past earnings growth

How has ANIP's earnings growth performed historically?

Company
202.92%
Industry
50.13%
Market
92.1%
ANIP's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ANIP's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ANIP's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ANIP earnings history

Current Revenue
$1.0B
Current Earnings
$116.8M
Current Profit Margin
11.2%
ANIP's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

ANIP Return on Equity

Current Company
20%
Current Industry
6.4%
Current Market
35.9%
ANIP's Return on Equity (20%)... subscribe to Premium to read more.
High Return on Equity Performance

ANIP Return on Assets

Current Company
7.9%
Current Industry
3.4%
ANIP is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ANIP announces earnings.

ANIP Return on Capital Employed

Current Company
13.94%
Current Industry
38.6%
ANIP has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ANIP vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ANIP$257.36M$116.84M+206.25%$5.18
ALVO$167.98M-$179.59MN/A-$0.62
TRLV-$118.38M-$445.60MN/A-$2.31
PCRX$134.28M$37.73M-7.33%$0.95
PAHC$235.78M$102.71M+16.18%$2.54

Ani Pharmaceuticals Earnings Reports & History FAQ

What were Ani Pharmaceuticals's earnings last quarter?

On ANIP's earnings call on Nov 5, 2026, Ani Pharmaceuticals (NASDAQ: ANIP) reported Q3 2026 earnings per share (EPS) of $1.54, up 29.41% year over year. Total ANIP earnings for the quarter were $35.15 million. In the same quarter last year, Ani Pharmaceuticals's earnings per share (EPS) was $1.19.

If you're new to stock investing, here's how to buy Ani Pharmaceuticals stock.

Is Ani Pharmaceuticals profitable or losing money?

As of the last Ani Pharmaceuticals earnings report, Ani Pharmaceuticals is currently profitable. Ani Pharmaceuticals's net profit (also called net income) for the twelve months ending Sep 30, 2026 was $116.84 million, a 187.99% increase year over year.

What was ANIP's earnings growth in the past year?

As of Ani Pharmaceuticals's earnings date in Nov 5, 2026, Ani Pharmaceuticals's earnings has grown 202.92% year over year. This is 152.79 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 50.13%. ANIP earnings in the past year totalled $116.84 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.